New York · 2025 Regular Session · Bill

A 9360: Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for certain purposes

In committee Last action January 7, 2026: REFERRED TO HEALTH

Plain-language summary

A 9360 is a bill introduced in the New York House on December 19, 2025. According to its official title, it concerns: Relates to requiring Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for certain purposes. Primary sponsor: Angelo Santabarbara (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.

Sponsors

Primary sponsor: Angelo Santabarbara (Democratic).